MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Freeline Therapeutics Holdings plc (NASDAQ: FRLN)
Organization & Developments: Freeline Therapeutics
Parents
Freeline Therapeutics Holdings plc (NASDAQ: FRLN)
Children
2020: Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves_xconomy
2022: Freeline Therapeutics Holdings (FRLN) Investor Presentation - Slideshow_ seekingalpha.com
2023: Freeline Reports Third Quarter 2022 Financial Results and Corporate Update
Biotechnology company that develops liver directed gene therapies for bleeding disorders and other diseases.
Its therapies are based on next-generation proprietary AAV vector platform, with its lead program being a gene therapy to treat haemophilia B.
Jumps
Finance & Acquisitions: Freeline Therapeutics
Key People: Freeline Therapeutics